The CLL14 trial: longer progression-free survival for CLL patients with coexisting conditions treated with venetoclax
1. In untreated chronic lymphocytic leukemia (CLL) patients with coexisting conditions, patients treated with venetoclax–obinutuzumab experienced greater progression-free survival compared...